The hospitalization rate and clinical characteristics of mucormycosis prior and during COVID-19 pandemic: A single-center study
Conclusions: In high-risk patients, especially diabetics, special care to avoid the development of mucormycosis must be taken into account in patients with SARS-COV-2 infection considered for treatment with corticosteroids.
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Authors: Mehrdad Estakhr, Zahra Ghotbi, Mahtab Rostamihosseinkhani, Etrat Hooshmandi, Masoud Janipour, Vahid Reza Ostovan, Nima Fadakar, Hanieh Bazrafshan, Zahra Bahrami, Abbas Rahimi-Jaberi, Maryam Poursadeghfard, Masoumeh Nazeri, Pariya Kouhi, Peyman Petramfar, Source Type: research
More News: Brain | Corticosteroid Therapy | COVID-19 | Diabetes | Endocrinology | Infectious Diseases | Iran Health | Middle East Health | Neurology | Pandemics | SARS | Study